By Rishika Sadam March 31 (Reuters) - Novo Nordisk has again cut the prices of its blockbuster diabetes and weight-loss drugs ...
One of the world’s leading healthcare names, Novo Nordisk (NYSE:NVO) cut prices on Wegovy and Ozempic by up to 48% in India ...
Sudden availability of so many cheap versions has raised concerns among health care professionals about malpractice and ...
Weight-loss and diabetes drugs like Ozempic have exploded in popularity, but high prices and limited insurance coverage have ...
Soon-to-be brides and grooms seeking shortcuts to shed pounds before the big day have become the latest consumer target for ...
Novo and Lilly launched their obesity drugs in India last year. The market is forecast to reach ₹80 billion ($851.79 million) ...
By Rishika Sadam HYDERABAD, India, April 3 (Reuters) - Soon-to-be brides and grooms seeking shortcuts to shed pounds before ...
Many Indian marriages are arranged by families, often bringing expectations around physical appearance and financial status ...
The drugmaker hasn't said its last word yet, as the weight-loss drug battle continues to heat up.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results